- 0203 3138 117
Dr Edward Bataillard studied biochemistry at Cambridge University, and graduated in medicine from Oxford University. He undertook his foundation and internal medical training in North West London, and specialist training in haematology under Imperial College. He has a specialist interest in lymphoma and cellular therapies.
Lymphoma, CLL, CAR-T cell therapy, stem cell transplantation, general haematology
Research & publications
Harris W, Bataillard EJ, Choi Y, El-Galaly TC, Cuchelkar V, Henneges C, Kwan A, Schneider DJ, Paulson JN, Nielsen TG. TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma. JCO Clin Cancer Inform. 2022 Jan;6:e2100121. doi: 10.1200/CCI.21.00121. PMID: 35044836.
Bataillard EJ, Cheah CY, Maurer MJ, Khurana A, Eyre TA, El-Galaly TC. Impact of R-CHOP dose intensity on survival outcomes in diffuse large B-cell lymphoma: a systematic review. Blood Adv. 2021 May 11;5(9):2426-2437. doi: 10.1182/bloodadvances.2021004665. PMID: 33961018; PMCID: PMC8114545.